Sonic Fund II, L.P. - 31 Dec 2025 SCHEDULE 13G/A Report for Fennec Pharmaceuticals Inc. Common stock, no par value (the "Shares") (FENC)

Filing Manager
Sonic Fund II, L.P.
Reporting Manager
Kam Lawrence
Security
Fennec Pharmaceuticals Inc. Common stock, no par value (the "Shares")
Symbol
FENC
Shares outstanding
34,145,841 shares
Disclosed Ownership
2,799,959 shares
Ownership
8.2%
Form type
SCHEDULE 13G/A
Filing time
17 Feb 2026, 10:39:33 UTC
Date of event
31 Dec 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Sonic Fund II, L.P. disclosed 8.2% ownership in Fennec Pharmaceuticals Inc. Common stock, no par value (the "Shares") (FENC) on 31 Dec 2025."

Quick Takeaways

  • Sonic Fund II, L.P. filed SCHEDULE 13G/A for Fennec Pharmaceuticals Inc. Common stock, no par value (the "Shares") (FENC).
  • Disclosed ownership: 8.2%.
  • Date of event: 31 Dec 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 17 Feb 2026, 10:39.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Sonic Fund II, L.P. 7.6% 2,607,357 0 2,607,357 /s/ Lawrence Kam Lawrence Kam, Managing Member of Sonic GP LLC, its General Partner
Sonic GP LLC 7.6% 2,607,357 0 2,607,357 /s/ Lawrence Kam Lawrence Kam, Managing Member
Kam Lawrence 8.2% 2,799,959 190,202 2,607,357 /s/ Lawrence Kam Lawrence Kam, a natural person

Sponsored